0001562180-19-000853.txt : 20190208 0001562180-19-000853.hdr.sgml : 20190208 20190208162747 ACCESSION NUMBER: 0001562180-19-000853 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190206 FILED AS OF DATE: 20190208 DATE AS OF CHANGE: 20190208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Meyers Michael L. CENTRAL INDEX KEY: 0001664204 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37708 FILM NUMBER: 19580262 MAIL ADDRESS: STREET 1: C/O SYNDAX PHARMACEUTICALS, INC. STREET 2: 400 TOTTEN POND ROAD, SUITE 110 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc CENTRAL INDEX KEY: 0001395937 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 320162505 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 GATEHOUSE DRIVE STREET 2: BUILDING D, FLOOR 3 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-419-1400 MAIL ADDRESS: STREET 1: 35 GATEHOUSE DRIVE STREET 2: BUILDING D, FLOOR 3 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-02-06 false 0001395937 Syndax Pharmaceuticals Inc SNDX 0001664204 Meyers Michael L. C/O SYNDAX PHARMACEUTICALS, INC. 35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3 WALTHAM MA 02451 false true false false SVP, Chief Medical Officer Common Stock 2019-01-31 4 J false 3720.00 4.76 A 6118.00 D Stock Option (Right to Buy) 6.38 2019-02-06 4 A false 104325.00 0.00 A 2029-02-06 Common Stock 104325.00 104325.00 D The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 3,720 shares by the Reporting Person on 01/31/2019 pursuant to the Issuer's Employee Stock Purchase Plan. The securities awarded on 02/06/2019 were in the form of stock options issued pursuant to the Syndax Pharmaceuticals, Inc. 2015 Omnibus Incentive Plan. Options to purchase 50,825 shares of common stock shall vest in 48 successive equal monthly installments measured from 02/06/2019. Options to purchase 53,500 shares of common stock shall vest periodically upon the Issuer achieving certain milestones. /s/ Michael A. Metzger, Attorney-in-Fact 2019-02-08